Pulmonary arterial wall distensibility assessed by intravascular ultrasound in children with congenital heart disease - An indicator for pulmonary vascular disease?

被引:34
|
作者
Berger, RMF
Cromme-Dijkhuis, AH
Hop, WCJ
Kruit, MN
Hess, J
机构
[1] Univ Rotterdam Hosp, Sophia Childrens Hosp, Dept Pediat, Div Pediat Cardiol, NL-3000 CB Rotterdam, Netherlands
[2] Erasmus Univ, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
[3] Tech Univ Munich, German Heart Ctr, Dept Pediat Cardiol, D-8000 Munich, Germany
关键词
dynamics; vascular; heart defects; congenital; hypertension; pulmonary; pulmonary vascular disease; ultrasund; intravascular;
D O I
10.1378/chest.122.2.549
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Both pulmonary hypertension and pulmonary overflow are associated with functional and structural changed of the pulmonary arterial wall. Current techniques to evaluate the pulmonary vasculature neglect the pulsatile nature of pulmonary flow. Study objectives: To determine whether the dynamic properties of the pulmonary arterial wall are altered in patients with abnormal pulmonary hemodynamics due to congenital heart defects, and whether these changes are associated with the progression of pulmonary vascular disease (PVD). Patients and methods: In 43 children with PAD due to congenital heart defects and 12 control subjects, pulmonary arterial pulsafility (the relative increase in vessel area during the cardiac cycle) and distensibility (the inverse of the stress/strain elastic modulus) were determined with intravascular ultrasound. Results were correlated with clinical and hemodynamic parameters. Results: Pulsatility correlated with pulmonary pulse pressure (p < 0.001), pulmonary-to-systemic vascular resistance ratio (PVR/SVR) [p = 0.001], and hemoglobin concentration (p = 0.01). However, when corrected for these variables, pulsatility did not differ between patients and control subjects. in contrast, arterial wall distensibility decreased with the severity of PVD and correlated independently with pulmonary-to-systemic arterial pressure ratio (p < 0.061) and PVR/SVR (p = 0.03), and with hemoglobin concentration (p < 0.01). Adjusted for hemodynamic variables, distensibility was still decreased in patients with PVD compared to control subjects. Conclusions: These results demonstrate that pulmonary arterial wall distensibility is progressively decreased in PVD; moreover, this decreased distensibility is, in part, related to increased distending pressure as a result of pulmonary hypertension but also, in part, to stiffening of the arterial wall during the disease process. Arterial wall distensibility may be of additional value in the evaluation of pulmonary vasculature and ventricular workload.
引用
收藏
页码:549 / 557
页数:9
相关论文
共 50 条
  • [41] THE ROLE OF THE PULMONARY VASCULAR BED IN CONGENITAL HEART DISEASE
    DAMMANN, JF
    MULLER, WH
    PEDIATRICS, 1953, 12 (03) : 307 - 325
  • [42] Feasibility of lung ultrasound to assess pulmonary overflow in congenital heart disease children
    Wu, Lei
    Hou, Qiaoru
    Lu, Yingying
    Bai, Jie
    Sun, Liping
    Huang, Yue
    Zhang, Mazhong
    Zheng, Jijian
    PEDIATRIC PULMONOLOGY, 2018, 53 (11) : 1525 - 1532
  • [43] The index of pulmonary vascular disease in children with congenital heart disease: relationship to clinical and haemodynamic findings
    M. Gorenflo
    M. Ullmann
    C. Sebening
    K. Brockmeier
    S. Hagl
    H. Ulmer
    H. Otto
    P. Schnabel
    Virchows Archiv, 2002, 441 : 264 - 270
  • [44] The index of pulmonary vascular disease in children with congenital heart disease: relationship to clinical and haemodynamic findings
    Gorenflo, M
    Ullmann, M
    Sebening, C
    Brockmeier, K
    Hagl, S
    Ulmer, HE
    Otto, HF
    Schnabel, PA
    VIRCHOWS ARCHIV, 2002, 441 (03) : 264 - 270
  • [45] SYSTEMIC AND PULMONARY VASCULAR EFFECTS OF PROPOFOL IN CHILDREN WITH CONGENITAL HEART-DISEASE
    WILLIAMS, GD
    HANSON, KA
    GEIDUSCHEK, JM
    JONES, TK
    BAPTISTE, D
    MORRAY, JP
    ANESTHESIOLOGY, 1994, 81 (3A) : A1372 - A1372
  • [46] Vascular remodeling process in reversibility of pulmonary arterial hypertension secondary to congenital heart disease
    Egito, EST
    Aiello, VD
    Bosisio, IBJ
    Lichtenfels, AJ
    Horta, ALM
    Saldiva, PHN
    Capelozzi, VL
    PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (08) : 521 - 532
  • [47] Intravenous sildenafil (Viagra®) and pulmonary vascular resistance in children with congenital heart disease
    Schulze-Neick, I
    Li, J
    Petros, A
    Redington, AN
    EUROPEAN HEART JOURNAL, 2001, 22 : 76 - 76
  • [49] Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease
    Zhou, Jing-jing
    Li, Huang
    Qian, Yu-ling
    Quan, Rui-lin
    Chen, Xiao-xi
    Li, Li
    Li, Yue
    Wang, Pei-he
    Meng, Xian-min
    Jing, Xiao-li
    He, Jian-guo
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 149 : 41 - 53
  • [50] Pulmonary Embolism in Congenital Heart Disease with Pulmonary Arterial Hypertension: a Case Series
    Ibrahim, M.
    Saboe, A.
    Kartamihardja, A. H. A.
    Cool, C. J.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F)